Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Healthequity (HQY) Shares Repurchased (2024 - 2026)

Healthequity has reported Shares Repurchased over the past 3 years, most recently at $81.0 million for Q1 2026.

For Q1 2026, Shares Repurchased rose 28.64% year-over-year to $81.0 million; the TTM value through Jan 2026 reached $299.3 million, up 146.31%, while the annual FY2026 figure was $299.3 million, 146.31% up from the prior year.
Shares Repurchased for Q1 2026 was $81.0 million at Healthequity, down from $92.4 million in the prior quarter.
Over five years, Shares Repurchased peaked at $92.4 million in Q4 2025 and troughed at $58.5 million in Q4 2024.
A 3-year average of $70.1 million and a median of $64.9 million in 2025 define the central range for Shares Repurchased.
Biggest five-year swings in Shares Repurchased: skyrocketed 57.95% in 2025 and later rose 28.64% in 2026.
Year by year, Shares Repurchased stood at $58.5 million in 2024, then skyrocketed by 57.95% to $92.4 million in 2025, then fell by 12.34% to $81.0 million in 2026.
Business Quant data shows Shares Repurchased for HQY at $81.0 million in Q1 2026, $92.4 million in Q4 2025, and $66.7 million in Q3 2025.